Related Experiment Video
Updated: May 19, 2026

Robust Ligature-Induced Model of Murine Periodontitis for the Evaluation of Oral Neutrophils
Published on: January 21, 2020
Maternal Periodontal Health
1Department of Obstetrics & Gynecology Atal Bihari Vajpayee Institute of Medical Sciences &, Dr Ram Manohar Lohia Hospital, New Delhi, India.
Background:
Periodontal disease is a highly prevalent inflammatory condition that tends to worsen during pregnancy due to hormonal, vascular, and immune changes. Emerging data suggests that poor maternal periodontal health may influence pregnancy outcomes, yet it often remains overlooked and uncared in routine antenatal care.
Objectives:
This review was written to summarize the global and Indian burden of periodontal disease in pregnancy, explain its biological mechanisms, and evaluate its association with adverse perinatal outcomes, along with available preventive and treatment strategies.
Methods:
A targeted search of PubMed, Google Scholar, and Embase (2015 onwards) was conducted. Of 206 articles screened, 44 met eligibility criteria and were included. Studies describing epidemiology, pathophysiology, diagnostic features, maternal-foetal effects, and treatment outcomes were reviewed. Select earlier studies were added for diagnostic and therapeutic clarity.
Results:
Globally, pregnancy-related gingivitis affects majority of women, with periodontitis prevalence varying widely across regions, including India. Periodontal inflammation may elevate systemic cytokines and bacterial endotoxins, contributing to preeclampsia, gestational diabetes, preterm birth, low birth weight, and foetal growth restriction. Non-surgical periodontal therapy in the second trimester is safe and may modestly reduce preterm birth and low birth weight, though findings vary across studies.
Conclusion:
Maternal periodontal disease is a modifiable risk factor with important implications for pregnancy outcomes. Integrating oral health screening, counselling, and timely periodontal care into antenatal services could support healthier maternal and neonatal outcomes. Further well-designed trials are needed to define the magnitude of benefit from treatment.
Related Concept Videos
Development of the Oral Microbiota
The Oral Microbiota
Development of Human Microbiota
Teeth
In the bud stage, the tooth germ (an aggregation of cells) starts to form in the developing jawbone. During the cap stage, the tooth germ differentiates into enamel organ, dental papilla, and dental sac, which will later develop into the tooth's enamel, dentin and...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
